Combination Antithrombotic Thrombotic therapy for prevention of recurrent Ischemic Stroke in patients with IntraCranial Atherosclerotic Disease (CATIS-ICAD)

联合抗血栓治疗预防颅内动脉粥样硬化性疾病患者复发性缺血性中风 (CATIS-ICAD)

• 批准号: 444831
• 负责人: Perera Kanjana S
• 金额: $ 24.52万
• 依托单位: McMaster University
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-04-01 至 2023-08-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=444831&lang=en
• 关键词: Combination Antithrombotic Therapy; Intracranial Atherosclerotic Disease; Ischemic Stroke; Low-Dose Rivaroxaban Plus Aspirin; Rivaroxaban; Stroke Secondary Prevention; Transient Ischemic Attack

Stroke is the 3rd leading cause of death and primary cause of disability in Canada and globally. Stroke caused by narrowing of the brain arteries from cholesterol plaques is the commonest cause of stroke. Many patients with narrowing of brain arteries suf

中风是加拿大和全球第三大死亡原因和主要残疾原因。由胆固醇斑块引起的脑动脉狭窄引起的中风是中风最常见的原因。许多患有脑动脉狭窄的患者